Skip to main content

Amgen, Illumina, Wyeth, Affymetrix, HistoRx, BobCat, GenoSensor

Premium
Amgen to Use Illumina Genotyping Technology in Large Women's Health Study
 
Illumina last week said that Amgen will use its genotyping technology as part of a large women's health study. 
 
Under the agreement, Illumina will provide its HumanHap300-Duo BeadChip to Amgen, which will work with researchers at the Brigham and Women’s Hospital to genotype women who have been clinically tracked for a decade.
 
The research is part of the Women’s Genome Health Study, which follows 28,000 women in an effort to identify genetic variations to try to find genetic clues to illnesses such as heart disease, diabetes, breast cancer, osteoporosis, and others
 
Financial terms of the deal were not disclosed.
 

 
Wyeth Extends Affymetrix Supply Deal for Three More Years
 
Wyeth has extended an ongoing microarray supply agreement with Affymetrix for three more years, Affymetrix said last week.
 
Under the terms of the agreement, originally signed in 1994, Wyeth will continue to use Affy’s GeneChip technology to identify new drug targets and to study genetic markers linked to therapeutic response.
 
Affy said Wyeth also uses its GeneChip products for disease classification and in predicting clinical progression.
 
No financial terms of the deal were released.
 

 
HistoRx Licenses AQUA Rights to Four Centers
 
HistoRx last week said it has licensed its AQUA biomarker-analysis technology to four research institutes.
 
The non-commercial agreements went to Brigham and Women’s Hospital, the Mayo Clinic, the Lee Moffitt Cancer Center and Research Institute, and the University of Wisconsin-Madison’s School of Medicine and Public Health.
 
HistoRx said these institutes will use the platform to measure localization and concentration of clinically relevant proteins in diseased tissues, which will aid in developing drugs and in making treatment decisions.
 

 
BobCat to Distribute GenoSensor’s GenoExplorer Chips in Europe
 
GenoSensor this week said that it has signed a distribution deal with the German life sciences company BioCat.
 
Under the terms of the agreement, BioCat will exclusively distribute Tempe, Ariz.-based GenoSensor’s GenoExplorer miRNA array products throughout the European Union.
 
Further details were not discussed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.